CONSOLIDATED STATEMENT OF CASH FLOWS (USD $)	3 Months Ended		59 Months Ended
	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2012
CASH FLOW FROM OPERATING ACTIVITIES
Net loss	$ (522,227)	$ (592,726)	$ (10,070,974)
Adjustments to reconcile net loss to net cash used in operating activities
Amortization	48,109	51,756	839,572
Technology impairment			345,000
Common stock issued for services			300,000
Stock options and warrants	19,356	119,981	2,969,725
(Increase) decrease in assets
Grants receivable		244,479
Prepaid drug product for testing	132,000	88,400	(21,000)
Other current assets	(7,891)	21,988	(56,330)
Increase (decrease) in liabilities
Accounts payable and accrued expenses	(69,536)	(58,849)	246,595
Net cash used in operating activities	(400,189)	(124,971)	(5,447,412)
CASH FLOW FROM INVESTING ACTIVITIES
Purchase of exclusive license - related party	(25,000)	(32,432)	(884,710)
Net cash used in investing activities	(25,000)	(32,432)	(884,710)
CASH FLOW FROM FINANCING ACTIVITIES
Proceeds from convertible notes			435,000
Cash repayment of convertible notes			(15,000)
Net proceeds from sale of common stock	49,760	684,606	6,488,945
Net cash from financing activities	49,760	684,606	6,908,945
NET INCREASE (DECREASE) IN CASH	(375,429)	527,203	576,823
Cash, beginning of period	952,252	238,565
Cash, end of period	576,823	765,768	576,823
Cash paid for
Interest			445
Income taxes
Non-cash financing activities
Common stock issued upon conversion of convertible notes			420,000
Placement Agent
Non-cash financing activities
Common stock issued			591,566
MD Anderson for License
Non-cash financing activities
Common stock issued			2,354,167
Lincoln Park Capital Fund, LLC
Non-cash financing activities
Common stock issued	$ 625		$ 209,630